SULFONYLUREA RECEPTOR SHORT FORMS FROM MITOCHONDRIA AND USES THEREOF
    31.
    发明申请
    SULFONYLUREA RECEPTOR SHORT FORMS FROM MITOCHONDRIA AND USES THEREOF 审中-公开
    来自麻醉药的SUFFYYURURA受体短型及其用途

    公开(公告)号:US20080293087A1

    公开(公告)日:2008-11-27

    申请号:US11931916

    申请日:2007-10-31

    CPC分类号: C07K14/705

    摘要: The present invention relates to isolated sulfonylurea receptor polynucleotides and polypeptides, as well as vectors and cells lines containing the polynucleotides and polypeptides. The present invention also relates to methods of using cell lines containing the polynucleotides and polypeptides to identify agents that are useful in ischemic preconditioning.

    摘要翻译: 本发明涉及分离的磺酰脲受体多核苷酸和多肽,以及含有多核苷酸和多肽的载体和细胞系。 本发明还涉及使用含有多核苷酸和多肽的细胞系来鉴定可用于缺血预处理的试剂的方法。

    Lights-guided piano learning and teaching apparatus, and method

    公开(公告)号:US11087636B2

    公开(公告)日:2021-08-10

    申请号:US15957966

    申请日:2018-04-20

    IPC分类号: G09B15/02 G09B15/00 G10C3/12

    摘要: Disclosed are a method, a device and/or a system of a lights-guided piano key learning and teaching device. In one aspect, a piano teaching apparatus includes an elongated enclosure overlaid atop a portion of a set of keys of a piano and a set of lights, each light corresponding with each key of the set of keys respectively. A depth of an underside of the elongated enclosure permits the set of keys to be played in an unobstructed manner. The set of light illuminates when an application of a data processing system communicatively coupled with the piano teaching apparatus communicates a set of instructions synchronized with a musical note of a compilation displayed on the application of the data processing device. The musical note corresponds with a particular light that is directly above a particular key of the set of keys associated with the musical note.

    LIGHTS-GUIDED PIANO LEARNING AND TEACHING APPARATUS, AND METHOD

    公开(公告)号:US20190325776A1

    公开(公告)日:2019-10-24

    申请号:US15957966

    申请日:2018-04-20

    IPC分类号: G09B15/02 G10C3/12

    摘要: Disclosed are a method, a device and/or a system of a lights-guided piano key learning and teaching device. In one aspect, a piano teaching apparatus includes an elongated enclosure overlaid atop a portion of a set of keys of a piano and a set of lights, each light corresponding with each key of the set of keys respectively. A depth of an underside of the elongated enclosure permits the set of keys to be played in an unobstructed manner. The set of light illuminates when an application of a data processing system communicatively coupled with the piano teaching apparatus communicates a set of instructions synchronized with a musical note of a compilation displayed on the application of the data processing device. The musical note corresponds with a particular light that is directly above a particular key of the set of keys associated with the musical note.

    Heterocyclic pyridone compound, and intermediate, preparation method and use thereof
    38.
    发明授权
    Heterocyclic pyridone compound, and intermediate, preparation method and use thereof 有权
    杂环吡啶酮化合物及其中间体,其制备方法和用途

    公开(公告)号:US09562060B2

    公开(公告)日:2017-02-07

    申请号:US14124628

    申请日:2012-05-28

    摘要: The present invention relates to a heterocyclic pyridone compound represented by General Formula (I), where the heterocyclic pyridone compound is used as a tyrosine kinase inhibitor, and particularly a c-Met inhibitor. The present invention also relates to intermediates for preparing heterocyclic pyridone compound and a preparation method. The present invention further relates to a pharmaceutical composition containing the heterocyclic pyridone compound as an active ingredient, and a use of the pharmaceutical composition in treatment of diseases associated with tyrosine kinase c-Met, especially cancer associated with c-Met, as a medicament.

    摘要翻译: 本发明涉及由通式(I)表示的杂环吡啶酮化合物,其中杂环吡啶酮化合物用作酪氨酸激酶抑制剂,特别是c-Met抑制剂。 本发明还涉及制备杂环吡啶酮化合物的中间体及其制备方法。 本发明还涉及含有杂环吡啶酮化合物作为活性成分的药物组合物,以及该药物组合物用于治疗与酪氨酸激酶c-Met相关疾病,特别是与c-Met相关的癌症作为药物的用途。

    System and method for wireless detector application in medical systems
    39.
    发明授权
    System and method for wireless detector application in medical systems 有权
    医疗系统中无线检测器应用的系统和方法

    公开(公告)号:US09081082B2

    公开(公告)日:2015-07-14

    申请号:US13299866

    申请日:2011-11-18

    申请人: Xinyu Zhang Bin Ye

    发明人: Xinyu Zhang Bin Ye

    摘要: A system for wireless detector application in a medical system is provided. The system includes at least three host wire adapters configured to receive beacon messages broadcast periodically by a wireless detector, and obtain information about the wireless detector based on the received beacon messages. The system further includes a controller configured to receive information about the wireless detector from the at least three host wire adapters, and determine a position of the wireless detector based on the received information.

    摘要翻译: 提供了一种用于医疗系统中的无线检测器应用的系统。 该系统包括被配置为接收由无线检测器周期性广播的信标消息的至少三个主机线适配器,并且基于接收到的信标消息获得关于无线检测器的信息。 该系统还包括控制器,其被配置为从至少三个主机线适配器接收关于无线检测器的信息,并且基于接收到的信息来确定无线检测器的位置。

    Urinary CA125 peptides as biomarkers of ovarian cancer
    40.
    发明授权
    Urinary CA125 peptides as biomarkers of ovarian cancer 有权
    尿CA125肽作为卵巢癌生物标志物

    公开(公告)号:US08642347B2

    公开(公告)日:2014-02-04

    申请号:US12865508

    申请日:2009-01-30

    申请人: Bin Ye Daniel Cramer

    发明人: Bin Ye Daniel Cramer

    CPC分类号: G01N33/57449 C07K14/4748

    摘要: The present invention is directed to diagnostic methods based upon the detection of peptides derived from the degradation of CA125. In particular, it is concerned with assays of urine samples collected from women for the purpose of determining whether they are at increased risk for having ovarian cancer, have decreased their risk as the result of clinical or non-clinical procedures, to monitor the efficacy of a treatment method, or to determine whether cancer has recurred or advanced.

    摘要翻译: 本发明涉及基于检测衍生自CA125降解的肽的诊断方法。 特别地,它涉及从妇女收集的尿液样品的测定,以确定它们是否具有增加的患有卵巢癌的风险,降低其作为临床或非临床程序的结果的风险,以监测其功效 治疗方法,或确定癌症是否复发或进展。